AsymBio
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A synthetic biology company using advanced manufacturing for biologics and small molecule production.
Infectious DiseaseMetabolic Diseases
Technology Platform
Synthetic biology platform for the biosynthesis and scalable manufacturing of complex biologics and small molecule drugs.
Opportunities
Major opportunity to become a preferred manufacturer for next-generation, difficult-to-synthesize biologic and complex small molecule drugs.
Risk Factors
Significant technical and scale-up risks in moving from laboratory-scale biosynthesis to cost-effective, regulatory-compliant commercial manufacturing.
Competitive Landscape
Competes with traditional chemical and fermentation-based manufacturing giants by offering a potentially disruptive production paradigm.